We report a study of the feasibility of once-a-day amoxicillin to trea
t acute otitis media (AOM). Seventy-seven children between ages 7 mont
hs and 12 years with AOM participated in a double-blind, placebo-contr
olled trial. Subjects received amoxicillin 40 mg/kg/day for 10 days. T
hey were similar in age, sex, history of ear infections, and presentin
g symptoms. Group I received one total dose of amoxicillin and two dos
es of placebo daily. Group II received three divided doses of amoxicil
lin daily. Parents kept a daily diary of symptoms related to the child
's illness and possible medication side effects. Ten children were los
t to follow-up. In the remaining 67, pneumatic otoscopy and tympanomet
ry after 10 to 14 days revealed that AOM had resolved in 82% of group
I and 68% of group II. Groups showed no significant differences in per
sistence of middle ear effusion; 39% in group I and 24% in group II st
ill had fluid. Diaries showed no significant differences between group
s in medication side effects. Thus, reduced-frequency dosing for AOM s
eems feasible and more realistic than current regimens.